Literature DB >> 25392590

Izalpinin from fruits of Alpinia oxyphylla with antagonistic activity against the rat bladder contractility.

Yuan Yuan1, Yin-Feng Tan2, Peng Xu2, Hailong Li2, Yong-Hui Li2, Wen-Ya Chen3, Jun-Qing Zhang2, Feng Chen2, Guo-Jun Huang4.   

Abstract

BACKGROUND: Alpinia oxyphylla (Zingiberaceae), an herbaceous perennial plant, its capsular fruit is commonly used in traditional Chinese medicine for the treatment of different urinary incontinence symptoms including frequency, urgency and nocturia. These symptoms are similar to the overactive bladder syndrome. In our lab, we found that the 95% ethanol extract of the capsular fruits exhibited significant anti-muscarinic activity. Some constituents in capsular fruits including flavonoids (e.g., izalpinin and tectochrysin), diarylheptanoids (e.g., yakuchinone A and yakuchinone B) and sesquiterpenes (e.g., nootkatone), are regarded as representative chemicals with putative pharmacological activities.
OBJECTIVE: This study aimed to evaluate the in vitro antagonistic actions of izalpinin on carbachol-induced contraction of the rat detrusor muscle.
MATERIALS AND METHODS: In vitro inhibition of rat detrusor contractile response to carbachol was used to study the functional activity of izalpinin. The isolated detrusor strips of rats were mounted in organ baths containing oxygenated Krebs' solution. The cumulative consecutive concentration-response curves to carbachol-evoked contractions in strips of rat bladder were obtained.
RESULTS: Carbachol induced concentration-dependent contractions of isolated rat bladder detrusor strips. The vehicle DMSO had no impact on the contraction response. The contraction effects were concentration-dependently antagonized by izalpinin, with a mean EC50 value of 0.35 µM. The corresponding cumulative agonist concentration-response curves shifted right-ward.
CONCLUSIONS: Izalpinin exhibits inhibitory role of muscarinic receptor-related detrusor contractile activity, and it may be a promising lead compound to treat overactive bladder.

Entities:  

Keywords:  Izalpinin; antagonistic action; muscarinic receptor; rat bladder

Mesh:

Substances:

Year:  2014        PMID: 25392590      PMCID: PMC4202406          DOI: 10.4314/ajtcam.v11i4.18

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  12 in total

Review 1.  Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.

Authors:  S S Hegde; R M Eglen
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 2.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 3.  The medical management of urinary incontinence.

Authors:  Ahmed Shaban; Marcus J Drake; Hashim Hashim
Journal:  Auton Neurosci       Date:  2009-11-08       Impact factor: 3.145

Review 4.  New drug treatments for urinary incontinence.

Authors:  Dudley Robinson; Linda Cardozo
Journal:  Maturitas       Date:  2010-01-22       Impact factor: 4.342

Review 5.  The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Authors:  Christopher R Chapple; Vik Khullar; Zahava Gabriel; Dominic Muston; Caty Ebel Bitoun; David Weinstein
Journal:  Eur Urol       Date:  2008-06-20       Impact factor: 20.096

6.  In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.

Authors:  C Salcedo; S Davalillo; J Cabellos; C Lagunas; D Balsa; S Pérez-Del-Pulgar; M Ballarín; Ag Fernández
Journal:  Br J Pharmacol       Date:  2009-02-16       Impact factor: 8.739

7.  The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra.

Authors:  Tomonori Yamanishi; Christopher R Chapple; Kosaku Yasuda; Ken-Ichiro Yoshida; Russell Chess-Williams
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

8.  Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study.

Authors:  Atsushi Otsuka; Hitoshi Shinbo; Ko Hasebe; Rikiya Matsumoto; Seiichiro Ozono
Journal:  Int J Urol       Date:  2008-12       Impact factor: 3.369

Review 9.  Muscarinic receptors in the bladder: from basic research to therapeutics.

Authors:  Sharath S Hegde
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

10.  Management of urinary incontinence in women: clinical applications.

Authors:  Jayna M Holroyd-Leduc; Sharon E Straus
Journal:  JAMA       Date:  2004-02-25       Impact factor: 56.272

View more
  4 in total

1.  Chemical Diversity and Biological Activity of African Propolis.

Authors:  Natalia Blicharska; Veronique Seidel
Journal:  Prog Chem Org Nat Prod       Date:  2019

2.  Microbial Transformation of Yakuchinone A and Cytotoxicity Evaluation of Its Metabolites.

Authors:  Chen Huo; Fubo Han; Yina Xiao; Hyun Jung Kim; Ik-Soo Lee
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

3.  Analysis of Bioactive Components in the Fruit, Roots, and Leaves of Alpinia oxyphylla by UPLC-MS/MS.

Authors:  Li Ying; Deli Wang; Guankui Du
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-09       Impact factor: 2.629

Review 4.  Exploring the Use of Iris Species: Antioxidant Properties, Phytochemistry, Medicinal and Industrial Applications.

Authors:  Sohaib Khatib; Cecilia Faraloni; Latifa Bouissane
Journal:  Antioxidants (Basel)       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.